Serum levels of interleukin-34 and RANKL as multivariable predictors of bone erosion seen by ultrasonography in patients with ankylosing spondylitis

[1] Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendation for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheum. 2016; 68:282–98. WardMM DeodharA AklEA LuiA ErmannJ GenslerLS American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendation for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis Arthritis Rheum 2016 68 282 98 10.1002/art.39298512384026401991 Search in Google Scholar

[2] Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010; 6:75–81. MaksymowychWP Disease modification in ankylosing spondylitis Nat Rev Rheumatol 2010 6 75 81 10.1038/nrrheum.2009.25820125174 Search in Google Scholar

[3] Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, et al. Discovery of a cytokine and its receptor by function screening of extracellular proteome. Science. 2008; 320:807–11. LinH LeeE HestirK LeoC HuangM BoschE Discovery of a cytokine and its receptor by function screening of extracellular proteome Science 2008 320 807 11 10.1126/science.115437018467591 Search in Google Scholar

[4] Chihara T, Suzu S, Hassan R, Chutiwitoonchai N, Hiyoshi M, Motoyoshi K, et al. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010; 17:1917–27. ChiharaT SuzuS HassanR ChutiwitoonchaiN HiyoshiM MotoyoshiK IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation Cell Death Differ 2010 17 1917 27 10.1038/cdd.2010.6020489731 Search in Google Scholar

[5] Wei S, Nandi S, Chitu V, Yeung Y-G, Yu W, Huang M, et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor mediated regulation of myeloid cells. J Leukoc Biol. 2010; 88:495–505. WeiS NandiS ChituV YeungY-G YuW HuangM Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor mediated regulation of myeloid cells J Leukoc Biol 2010 88 495 505 10.1189/jlb.1209822292460520504948 Search in Google Scholar

[6] Chemel M, Le Goff B, Brion R, Cozic C, Berreur M, Amiaud J, et al. Interleukin 34 expression is associated with synovitis in rheumatoid arthritis patients. Ann Rheum Dis. 2012; 77:150–4. ChemelM Le GoffB BrionR CozicC BerreurM AmiaudJ Interleukin 34 expression is associated with synovitis in rheumatoid arthritis patients Ann Rheum Dis 2012 77 150 4 10.1136/annrheumdis-2011-200096341361722039170 Search in Google Scholar

[7] Tian Y, Shen H, Xia L, Lu J. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production. J Interferon Cytokine Res. 2013; 33:398–401. TianY ShenH XiaL LuJ Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production J Interferon Cytokine Res 2013 33 398 401 10.1089/jir.2012.0122370862423421370 Search in Google Scholar

[8] Moon S-J, Hong Y-S, Ju JH, Kwok S-K, Park S-H, Min J-K. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol. 2013; 40:1842–9. MoonS-J HongY-S JuJH KwokS-K ParkS-H MinJ-K Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis J Rheumatol 2013 40 1842 9 10.3899/jrheum.13035623996288 Search in Google Scholar

[9] Zhang F, Ding R, Li P, Ma C, Song D, Wang X, et al. Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy. Int J Clin Exp Med. 2015; 8:7809–15. ZhangF DingR LiP MaC SongD WangX Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy Int J Clin Exp Med 2015 8 7809 15 Search in Google Scholar

[10] Wang S-L, Zhang R, Hu K-Z, Li M-Q, Li Z-C. Interleukin-34 synovial fluid was associated with knee osteoarthritis severity: a cross-sectional study in knee osteoarthritis patients in different radiographic stages. Dis Markers 2018; 2018:2095480. doi: 10.1155/2018/2095480 WangS-L ZhangR HuK-Z LiM-Q LiZ-C Interleukin-34 synovial fluid was associated with knee osteoarthritis severity: a cross-sectional study in knee osteoarthritis patients in different radiographic stages Dis Markers 2018 2018 2095480. 10.1155/2018/2095480 610955630159102 Open DOISearch in Google Scholar

[11] Clavel G, Thiolat A, Boissier MC. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine. 2013; 80:449–453. ClavelG ThiolatA BoissierMC Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38 Joint Bone Spine 2013 80 449 453 10.1016/j.jbspin.2013.04.01423849463 Search in Google Scholar

[12] Mou Y-K, Zhang P-P, Li Q-X, Lin Z-M, Liao Z-T, Wei Q-J, Gu J-R. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes. Clin Rheumatol. 2015; 34:1085–9. MouY-K ZhangP-P LiQ-X LinZ-M LiaoZ-T WeiQ-J GuJ-R Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes Clin Rheumatol 2015 34 1085 9 10.1007/s10067-015-2940-z25912212 Search in Google Scholar

[13] Chen C-H, Chen H-A, Liao H-T, Liu C-H, Tsai C-Y, Chou C-T. Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol. 2010; 29:1155–61. ChenC-H ChenH-A LiaoH-T LiuC-H TsaiC-Y ChouC-T Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation Clin Rheumatol 2010 29 1155 61 10.1007/s10067-010-1543-y20690034 Search in Google Scholar

[14] Feydy A, Lavie-Brion MC, Gossec L, Lavie F, Guerini H, Nguyen C, et al. Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Ann Rheum Dis. 2012; 71:498–503. FeydyA Lavie-BrionMC GossecL LavieF GueriniH NguyenC Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls Ann Rheum Dis 2012 71 498 503 10.1136/annrheumdis-2011-20033621949008 Search in Google Scholar

[15] Kamel M, Eid H, Mansour R. Ultrasound detection of heel enthesitis: a comparison with magnetic resonance imaging. J Rheumatol. 2003; 30:774–8. KamelM EidH MansourR Ultrasound detection of heel enthesitis: a comparison with magnetic resonance imaging J Rheumatol 2003 30 774 8 Search in Google Scholar

[16] Li N, Jiang L, Cai Y, Liu JY, Zhao T, Kong N, et al. The correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritis. Mod Rheumatol. 2019; 30:269–75. LiN JiangL CaiY LiuJY ZhaoT KongN The correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritis Mod Rheumatol 2019 30 269 75 10.1080/14397595.2019.159357630880555 Search in Google Scholar

[17] Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Ann Intern Med. 2015; 162:55–63. CollinsGS ReitsmaJB AltmanDG MoonsKG Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement Ann Intern Med 2015 162 55 63 10.1161/CIRCULATIONAHA.114.014508429722025561516 Search in Google Scholar

[18] Schmidt SAJ, Lo S, Hollestein LM. Research techniques made simple: sample size estimation and power calculation. J Invest Dermatol. 2018; 138:1678–82. SchmidtSAJ LoS HollesteinLM Research techniques made simple: sample size estimation and power calculation J Invest Dermatol 2018 138 1678 82 10.1016/j.jid.2018.06.16530032783 Search in Google Scholar

[19] van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27:361–8. van der LindenS ValkenburgHA CatsA Evaluation of diagnostic criteria for ankylosing spondylitis A proposal for modification of the New York criteria. Arthritis Rheum 1984 27 361 8 Search in Google Scholar

[20] Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29:1039–49. AltmanR AschE BlochD BoleG BorensteinD BrandtK Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Arthritis Rheum 1986 29 1039 49 10.1002/art.17802908163741515 Search in Google Scholar

[21] Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34:505–14. AltmanR AlarcónG AppelrouthD BlochD BorensteinD BrandtK The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip Arthritis Rheum 1991 34 505 14 10.1002/art.17803405022025304 Search in Google Scholar

[22] Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009; 68:8–17. ZhangW DohertyM LeebBF AlekseevaL ArdenNK BijlsmaJW EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT Ann Rheum Dis 2009 68 8 17 10.1136/ard.2007.08477218250111 Search in Google Scholar

[23] Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010; 69:483–9. ZhangW DohertyM PeatG Bierma-ZeinstraMA ArdenNK BresnihanB EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis Ann Rheum Dis 2010 69 483 9 10.1136/ard.2009.11310019762361 Search in Google Scholar

[24] 中华医学会骨科学分会 [Chinese Medical Association Orthopaedic Branch]. 骨关节炎诊治指南(2007年版) [Guideline for diagnosis and treatment of osteoarthritis (2007 edition)]. 中华 骨科杂志 [Chin J Orthop]. 2007; 27:793–6. [in Chinese] 中华医学会骨科学分会 [Chinese Medical Association Orthopaedic Branch] 骨关节炎诊治指南(2007年版) [Guideline for diagnosis and treatment of osteoarthritis (2007 edition)] 中华 骨科杂志 [Chin J Orthop] 2007 27 793 6 [in Chinese] Search in Google Scholar

[25] Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990; 33:1601–10. AltmanR AlarcónG AppelrouthD BlochD BorensteinD BrandtK The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand Arthritis Rheum 1990 33 1601 10 10.1002/art.17803311012242058 Search in Google Scholar

[26] Balint PV, Kane D, Wilson H, Mclnnes IB, Sturrock RD. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002; 61:905–10. BalintPV KaneD WilsonH MclnnesIB SturrockRD Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy Ann Rheum Dis 2002 61 905 10 10.1136/ard.61.10.905175391312228161 Search in Google Scholar

[27] Zhao W, Huang F. 细胞核因子κB 受体活化因子配基在强直性脊 柱炎的表达及意义 [Expression and significance of nuclear factor κB receptor activator ligand in ankylosing spondylitis]. The role of RANKL in the pathogenesis of peripheral joint bone destruction in ankylosing spondylitis. Medical J Chin PLA. 2004; 29:482–5. [English title and abstract, article in Chinese] ZhaoW HuangF 细胞核因子κB 受体活化因子配基在强直性脊 柱炎的表达及意义 [Expression and significance of nuclear factor κB receptor activator ligand in ankylosing spondylitis]. The role of RANKL in the pathogenesis of peripheral joint bone destruction in ankylosing spondylitis Medical J Chin PLA 2004 29 482 5 [English title and abstract, article in Chinese] Search in Google Scholar

[28] Mori H, Kitazawa R, Mizuki S, Nose M, Maeda S, Kitazawa S. RANKL ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. Histochem Cell Biol. 2002; 117:283–92. MoriH KitazawaR MizukiS NoseM MaedaS KitazawaS RANKL ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse Histochem Cell Biol 2002 117 283 92 10.1007/s00418-001-0376-911914926 Search in Google Scholar

[29] Chen Z, Buki K, Vääräniemi J, Gu G, Väänänen HK. The critical role of IL-34 in osteoclastogenesis. PLoS One. 2011; 6:e18689. doi: 10.1371/journal.pone.0018689 ChenZ BukiK VääräniemiJ GuG VäänänenHK The critical role of IL-34 in osteoclastogenesis PLoS One 2011 6 e18689 10.1371/journal.pone.0018689 307298821494622 Open DOISearch in Google Scholar

[30] Baud’huin M, Renault R, Charrier C, Riet A, Moreau A, Brion R, et al. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 2010; 221:77–86. Baud’huinM RenaultR CharrierC RietA MoreauA BrionR Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis J Pathol 2010 221 77 86 10.1002/path.268420191615 Search in Google Scholar